Is SER or SGMO more undervalued in 2026?

CirclFi compares Serina Therapeutics, Inc. (SER) and Sangamo Therapeutics, Inc. (SGMO) using 13 institutional-grade valuation models. SER has a Quality of Company score of 4.9/10 while SGMO scores 5.2/10.

Which is a better buy — SER or SGMO?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do SER and SGMO valuations compare?

SER at $1.95 and SGMO at $0.21 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

SER vs SGMO Valuation Comparison 2026 — Intrinsic Value Analysis

SER

Biotechnology

Serina Therapeutics, Inc.

Quality

4.9

out of 10

Value Trap

LOW

Price

$1.95

Last close

Models

9/13

Active

SGMO

Biotechnology

Sangamo Therapeutics, Inc.

Quality

5.2

out of 10

Value Trap

LOW

Price

$0.21

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	SER Fair Value	SER Upside	SGMO Fair Value	SGMO Upside
Bayesian DCF	Intrinsic	$1.20	-38.7%	$0.05	-77.8%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$2.49	+27.7%	$0.46	+122.6%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for SER vs SGMO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

SER vs SGMO — Which Stock Is More Undervalued?

SGMO scores higher with a 5.2/10 quality rating vs SER's 4.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Serina Therapeutics, Inc. (SER) and Sangamo Therapeutics, Inc. (SGMO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

SER currently trades at $1.95 with a QOC of 4.9/10, while SGMO trades at $0.21 with a QOC of 5.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).